Low risk high reward: What should we worry about with coronavirus disease 2019 positive donors?
dc.contributor.author | Eichenberger, Emily M | |
dc.contributor.author | Kaul, Daniel R | |
dc.contributor.author | Wolfe, Cameron R | |
dc.date.accessioned | 2022-09-26T16:04:58Z | |
dc.date.available | 2023-09-26 12:04:56 | en |
dc.date.available | 2022-09-26T16:04:58Z | |
dc.date.issued | 2022-08 | |
dc.identifier.citation | Eichenberger, Emily M; Kaul, Daniel R; Wolfe, Cameron R (2022). "Low risk high reward: What should we worry about with coronavirus disease 2019 positive donors?." Transplant Infectious Disease 24(4): n/a-n/a. | |
dc.identifier.issn | 1398-2273 | |
dc.identifier.issn | 1399-3062 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/174836 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.title | Low risk high reward: What should we worry about with coronavirus disease 2019 positive donors? | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Microbiology and Immunology | |
dc.subject.hlbsecondlevel | Medicine (General) | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/174836/1/tid13892_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/174836/2/tid13892.pdf | |
dc.identifier.doi | 10.1111/tid.13892 | |
dc.identifier.source | Transplant Infectious Disease | |
dc.identifier.citedreference | Eichenberger EM, Kaul DR, Wolfe CR. The pandemic provides a pathway: what we know and what we need to know about using COVID positive donors. Transpl Infect Dis. 2021: e13727. doi: 10.1111/tid.13727 | |
dc.identifier.citedreference | Gaussen A, Hornby L, Rockl G, et al. Evidence of SARS‐CoV‐2 infection in cells, tissues, and organs and the risk of transmission through transplantation. Transplantation. 2021; 105 ( 7 ): 1405 ‐ 1422. doi: 10.1097/tp.0000000000003744 | |
dc.identifier.citedreference | Chertow D, Stein S, Ramelli S, et al. SARS‐CoV‐2 infection and persistence throughout the human body and brain. Res Square. 2021. doi: 10.21203/rs.3.rs‐1139035/v1 | |
dc.identifier.citedreference | Eichenberger E, Coniglio A, Milano C, et al. Transplanting thoracic COVID‐19 positive donors: overcoming the pandemic. Paper presented at: Oral presentation at proceedings of the 42nd international society for heart and lung transplantation. April 27–30, 2022, Boston, MA. | |
dc.identifier.citedreference | Romagnoli R, Gruttadauria S, Tisone G, et al. Liver transplantation from active COVID‐19 donors: a lifesaving opportunity worth grasping? Am J Transplant. 2021; 21 ( 12 ): 3919 ‐ 3925. doi: 10.1111/ajt.16823 | |
dc.identifier.citedreference | Yetmar ZA, Ranganath N, Huebert RC, Rosen CB, Razonable RR, Beam E. Successful liver transplantation from a SARS‐CoV‐2 positive donor to a positive recipient: potential role of monoclonal antibodies. Transplantation. 2022; 106 ( 3 ): e181 ‐ e182. doi: 10.1097/tp.0000000000004032 | |
dc.identifier.citedreference | Barros N, Ermel A, Mihaylov P, Lacerda M, Fridell J, Kubal C. Deceased donor liver transplantation from a SARS‐CoV‐2‐Positive donor to a SARS‐CoV‐2‐Positive recipient. Liver Transpl. 2021; 27 ( 12 ): 1849 ‐ 1851. doi: 10.1002/lt.26253 | |
dc.identifier.citedreference | Lee K, Desai NM, Resnick J, et al. Successful kidney transplantation from a deceased donor with severe COVID‐19 respiratory illness with undetectable SARS‐CoV‐2 in donor kidney and aorta. Am J Transplant. 2022; 22 ( 5 ): 1501 ‐ 1503. doi: 10.1111/ajt.16956 | |
dc.identifier.citedreference | La Hoz RM, Mufti AR, Vagefi PA. Short‐term liver transplant outcomes from SARS‐CoV‐2 lower respiratory tract NAT positive donors. Transpl Infect Dis. 2022; 24 ( 1 ): e13757. doi: 10.1111/tid.13757 | |
dc.identifier.citedreference | Molnar MZ, Hall IE, Raghavan D, et al. Kidney transplantation from SARS‐CoV‐2‐positive deceased donor. Am J Transplant. 2022; 22 ( 4 ): 1280 ‐ 1282. doi: 10.1111/ajt.16905 | |
dc.identifier.citedreference | Wall AE, McKenna GJ, Onaca N, et al. Utilization of a SARS‐CoV‐2‐positive donor for liver transplantation. Proc Bayl Univ Med Cent. 2022; 35 ( 1 ): 62 ‐ 63. doi: 10.1080/08998280.2021.1985888 | |
dc.identifier.citedreference | Royo‐Villanova Reparaz M, Dominguez‐Gil B, Moreno Docón A, Cánovas López SJ, Pastor Pérez FJ, Ortín Freire AJ. Organ donor with PCR positive for SARS‐CoV‐2, it has been always no?. Med Intensiva. 2022; 46 ( 4 ): 225 ‐ 226. doi: 10.1016/j.medine.2022.02.003 | |
dc.identifier.citedreference | OPTN. Summary of current evidence and information– donor SARS‐CoV‐2 testing & organ recovery from donors with a history of COVID‐19. Available at: https://optn.transplant.hrsa.gov/media/kkhnlwah/sars‐cov‐2‐summary‐of‐evidence.pdf Accessed May 25, 2022 | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.